Print Page  Close Window

2017 Press Releases

Keyword Search
 
Current | Archive
DateTitle 
11/02/17OraSure Technologies to Present at the 2017 Canaccord Genuity Medical Technologies & Diagnostics Forum
BETHLEHEM, Pa., Nov. 02, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the 2017 Canaccord Genuity Medical Technologies and Diagnostics Forum.  The conference will be simultaneously webcast over the Internet. Mr. Michels is scheduled to speak on November 9, 2017, at approximately 8:00 AM Eastern ... 
Printer Friendly Version
11/01/17OraSure Announces 2017 Third Quarter Financial Results
BETHLEHEM, Pa., Nov. 01, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its consolidated financial results for the three and nine months ended September 30, 2017. Financial Highlights Consolidated net revenues for the third quarter of 2017 were $42.3 million, a 31% increase from the third quarter of 2016. Consolidated net product revenues were $41.2 million, representing a 62% ... 
Printer Friendly Version
11/01/17OraSure Technologies to Present at the Stephens 2017 Fall Investment Conference
BETHLEHEM, Pa., Nov. 01, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the Stephens 2017 Fall Investment Conference.  The conference will be simultaneously webcast over the Internet. Mr. Michels is scheduled to speak on November 8, 2017, at approximately 11:00 AM Eastern Time (8:00 AM Pacific Time... 
Printer Friendly Version
10/11/17OraSure Technologies Earnings Conference Call Invitation
2017 Third Quarter Earnings Conference Call Wednesday, November 1, 2017, 5:00 p.m. ET BETHLEHEM, Pa., Oct. 11, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) has scheduled its regular earnings conference call covering 2017 third quarter financial results, 2017 fourth quarter financial guidance and certain business developments for 5:00 p.m. ET (2:00 p.m. PT) on Wednesday, November 1, 2017.  November 1, 2017 Schedule 4:00 p.m. ET 2017 third qua... 
Printer Friendly Version
09/20/17OraSure Technologies to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference
BETHLEHEM, Pa., Sept. 20, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the 2017 Cantor Fitzgerald Global Healthcare Conference.  The conference will be simultaneously webcast over the Internet. Mr. Michels is scheduled to speak on September 26, 2017, at approximately 2:15 PM Eastern Time (11:15 A... 
Printer Friendly Version
09/06/17OraSure Technologies to Present at CL King’s 15th Annual Best Ideas Conference
BETHLEHEM, Pa., Sept. 06, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment community at CL King’s 15th Annual Best Ideas Conference.  The conference will be simultaneously webcast over the Internet. Mr. Michels is scheduled to speak on September 14th, 2017, at approximately 11:45 AM Eastern Time (8:45 AM Pacific ... 
Printer Friendly Version
08/02/17OraSure Announces 2017 Second Quarter Financial Results
BETHLEHEM, Pa., Aug. 02, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its consolidated financial results for the three and six months ended June 30, 2017. Financial Highlights Consolidated net revenues for the second quarter of 2017 were $40.2 million, a 28% increase from the second quarter of 2016. Net product revenues were $39.1 million, representing a 42% increase over the... 
Printer Friendly Version
08/01/17OraSure Technologies to Present at the Canaccord Genuity 37th Annual Growth Conference
BETHLEHEM, Pa., Aug. 01, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the Canaccord Genuity 37th Annual Growth Conference in Boston, Massachusetts.  The conference will be simultaneously webcast over the Internet. Mr. Michels is scheduled to speak on August 10, 2017, at approximately 8:00 AM Ea... 
Printer Friendly Version
07/24/17OraQuick® HIV Self-Test Selected for Next Phase of STAR Project for HIV Self-Testing in Africa (revised July 27, 2017)
~Phase II of STAR Project Expected to Deploy 4 Million Additional HIV Self-Tests~ BETHLEHEM, Pa., July 24, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that its OraQuick® HIV Self-Test (HIVST) has been selected by UNITAID and Population Services International (PSI) for use in Phase II of the HIV Self-Testing Africa (STAR) Project. The STAR Project Phase II, beginning in Q4 of 201... 
Printer Friendly Version
07/21/17OraSure Technologies Receives World Health Organization Prequalification of OraQuick® HIV Self-Test
WHO Prequalification will enable procurement of OraQuick® HIV Self-Test with monies from global public health funding sources BETHLEHEM, Pa., July 21, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that its OraQuick® HIV Self-Test (HIVST) has been Prequalified by the World Health Organization (WHO). The OraQuick HIV Self-Test is a rapid, point-of-care test that allows an individual... 
Printer Friendly Version